Results 131 to 140 of about 76,081,297 (156)
Siglec-15 as an Emerging Target for Next-generation Cancer Immunotherapy. [PDF]
Sun J, Lu Q, Sanmamed MF, Wang J.
europepmc +1 more source
Bispecific Siglec-15/T cell antibody (STAB) activates T cells and suppresses pancreatic ductal adenocarcinoma and non-small cell lung tumors in vivo. [PDF]
Shen L +4 more
europepmc +1 more source
Siglec-15/sialic acid axis as a central glyco-immune checkpoint in breast cancer bone metastasis. [PDF]
Wang Y +11 more
europepmc +1 more source
Siglec-15 on macrophages suppress the immune microenvironment in patients with PD-L1 negative non-metastasis lung adenocarcinoma. [PDF]
Huang Z +7 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
CD24-Siglec Axis Is an Innate Immune Checkpoint Against Metaflammation and Metabolic Disorder
Cell Metabolism, 2022Guo-Yun Chen +2 more
exaly
Siglec and Anti-Siglec Therapies
Current Opinion in Chemical Biology, 2021Paul R. Crocker +2 more
exaly

